PortfoliosLab logo
IQV vs. LLY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between IQV and LLY is 0.42, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

IQV vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in IQVIA Holdings Inc. (IQV) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

IQV:

-1.09

LLY:

-0.23

Sortino Ratio

IQV:

-1.63

LLY:

-0.04

Omega Ratio

IQV:

0.80

LLY:

0.99

Calmar Ratio

IQV:

-0.74

LLY:

-0.32

Martin Ratio

IQV:

-1.72

LLY:

-0.59

Ulcer Index

IQV:

22.09%

LLY:

13.61%

Daily Std Dev

IQV:

34.09%

LLY:

38.49%

Max Drawdown

IQV:

-51.52%

LLY:

-68.27%

Current Drawdown

IQV:

-50.34%

LLY:

-22.74%

Fundamentals

Market Cap

IQV:

$24.28B

LLY:

$662.23B

EPS

IQV:

$7.33

LLY:

$12.54

PE Ratio

IQV:

19.14

LLY:

58.83

PEG Ratio

IQV:

0.86

LLY:

1.13

PS Ratio

IQV:

1.57

LLY:

13.51

PB Ratio

IQV:

4.06

LLY:

42.01

Total Revenue (TTM)

IQV:

$15.50B

LLY:

$49.00B

Gross Profit (TTM)

IQV:

$5.38B

LLY:

$40.03B

EBITDA (TTM)

IQV:

$3.40B

LLY:

$16.27B

Returns By Period

In the year-to-date period, IQV achieves a -28.59% return, which is significantly lower than LLY's -4.09% return. Over the past 10 years, IQV has underperformed LLY with an annualized return of 7.25%, while LLY has yielded a comparatively higher 27.48% annualized return.


IQV

YTD

-28.59%

1M

-7.13%

6M

-30.13%

1Y

-35.95%

3Y*

-13.29%

5Y*

-1.26%

10Y*

7.25%

LLY

YTD

-4.09%

1M

-6.92%

6M

-6.90%

1Y

-9.46%

3Y*

34.17%

5Y*

38.59%

10Y*

27.48%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


IQVIA Holdings Inc.

Eli Lilly and Company

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

IQV vs. LLY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IQV
The Risk-Adjusted Performance Rank of IQV is 44
Overall Rank
The Sharpe Ratio Rank of IQV is 22
Sharpe Ratio Rank
The Sortino Ratio Rank of IQV is 44
Sortino Ratio Rank
The Omega Ratio Rank of IQV is 66
Omega Ratio Rank
The Calmar Ratio Rank of IQV is 77
Calmar Ratio Rank
The Martin Ratio Rank of IQV is 22
Martin Ratio Rank

LLY
The Risk-Adjusted Performance Rank of LLY is 3535
Overall Rank
The Sharpe Ratio Rank of LLY is 3737
Sharpe Ratio Rank
The Sortino Ratio Rank of LLY is 3535
Sortino Ratio Rank
The Omega Ratio Rank of LLY is 3535
Omega Ratio Rank
The Calmar Ratio Rank of LLY is 3030
Calmar Ratio Rank
The Martin Ratio Rank of LLY is 3838
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

IQV vs. LLY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for IQVIA Holdings Inc. (IQV) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current IQV Sharpe Ratio is -1.09, which is lower than the LLY Sharpe Ratio of -0.23. The chart below compares the historical Sharpe Ratios of IQV and LLY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

IQV vs. LLY - Dividend Comparison

IQV has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.76%.


TTM20242023202220212020201920182017201620152014
IQV
IQVIA Holdings Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
LLY
Eli Lilly and Company
0.76%0.67%0.78%1.07%1.23%1.75%1.96%1.95%2.46%2.77%2.37%2.84%

Drawdowns

IQV vs. LLY - Drawdown Comparison

The maximum IQV drawdown since its inception was -51.52%, smaller than the maximum LLY drawdown of -68.27%. Use the drawdown chart below to compare losses from any high point for IQV and LLY.


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

IQV vs. LLY - Volatility Comparison

The current volatility for IQVIA Holdings Inc. (IQV) is 13.35%, while Eli Lilly and Company (LLY) has a volatility of 16.63%. This indicates that IQV experiences smaller price fluctuations and is considered to be less risky than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

IQV vs. LLY - Financials Comparison

This section allows you to compare key financial metrics between IQVIA Holdings Inc. and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


2.00B4.00B6.00B8.00B10.00B12.00B14.00B20212022202320242025
3.83B
12.73B
(IQV) Total Revenue
(LLY) Total Revenue
Values in USD except per share items

IQV vs. LLY - Profitability Comparison

The chart below illustrates the profitability comparison between IQVIA Holdings Inc. and Eli Lilly and Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%80.0%20212022202320242025
33.9%
82.5%
(IQV) Gross Margin
(LLY) Gross Margin
IQV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, IQVIA Holdings Inc. reported a gross profit of 1.30B and revenue of 3.83B. Therefore, the gross margin over that period was 33.9%.

LLY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Eli Lilly and Company reported a gross profit of 10.50B and revenue of 12.73B. Therefore, the gross margin over that period was 82.5%.

IQV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, IQVIA Holdings Inc. reported an operating income of 496.00M and revenue of 3.83B, resulting in an operating margin of 13.0%.

LLY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Eli Lilly and Company reported an operating income of 5.41B and revenue of 12.73B, resulting in an operating margin of 42.5%.

IQV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, IQVIA Holdings Inc. reported a net income of 249.00M and revenue of 3.83B, resulting in a net margin of 6.5%.

LLY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Eli Lilly and Company reported a net income of 2.76B and revenue of 12.73B, resulting in a net margin of 21.7%.